| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.22 | 0.0008 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.005 |